Reports and Accounting. 8.1. The Company shall give Yissum written notice of any (i) Sublicense Consideration received; (ii) First Commercial Sale made; or (iii) Milestone achieved; within 30 days of the particular event.
Appears in 4 contracts
Samples: Research and License Agreement (Scopus BioPharma Inc.), Research and License Agreement (Scopus BioPharma Inc.), Research and License Agreement (Scopus BioPharma Inc.)
Reports and Accounting. 8.1. The Company shall give Yissum written notice of any (i) Sublicense Consideration received; (ii) or First Commercial Sale made; or (iii) Milestone achieved; within 30 days of the particular event.made/
Appears in 2 contracts
Samples: License Agreement (Cannapowder, Inc.), License Agreement (Smart Energy Solutions, Inc.)
Reports and Accounting. 8.1. The Company shall give Yissum written notice of any (i) Sublicense Consideration received; and (ii) First Commercial Sale made; or within thirty (iii30) Milestone achieved; within 30 days of the particular event.
Appears in 2 contracts
Samples: Research and License Agreement (Therapix Biosciences Ltd.), Assignment Agreement (Therapix Biosciences Ltd.)
Reports and Accounting. 8.1. The Company shall give Yissum written notice of any (i) Sublicense Consideration received; (ii) First Commercial Sale made; or (iii) Milestone achieved; within 30 days of the particular event.)
Appears in 1 contract
Samples: Research and License Agreement (Virpax Pharmaceuticals, Inc.)
